Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by EpiBiologics

News headline image
EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
From EpiBiologics
Via Business Wire
News headline image
EpiBiologics Presents First Data on c-Met Degrading Bispecific Antibody
From EpiBiologics
Via Business Wire
News headline image
EpiBiologics to Present Data Demonstrating Disease-Selective Extracellular Protein Degradation and Platform Breadth at Upcoming Scientific Meetings
From EpiBiologics
Via Business Wire
News headline image
EpiBiologics Extracellular Protein Degraders Demonstrate Robust Preclinical Anti-tumor Activity and Survival Benefit
From EpiBiologics
Via Business Wire
News headline image
EpiBiologics Appoints Ann Lee-Karlon as Chief Executive Officer and President, Extends Series A Financing to Over $70 Million
From EpiBiologics
Via Business Wire
News headline image
EpiBiologics Launches with $50 million Series A Financing to Advance Next-Generation Protein Degradation Platform
From EpiBiologics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.